Risultati della ricerca - Anne E. Lykkesfeldt

  • Mostra 1 - 12 risultati su 12
Raffina i risultati
  1. 1
    Indirect mechanism of oestradiol stimulation of cell proliferation of human breast cancer cell lines

    Indirect mechanism of oestradiol stimulation of cell proliferation of human breast cancer cell lines di Anne E. Lykkesfeldt, Per Briand

    Pubblicazione 1986
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  2. 2
    Determination of HER2 phosphorylation at tyrosine 1221/1222 improves prediction of poor survival for breast cancer patients with hormone receptor-positive tumors

    Determination of HER2 phosphorylation at tyrosine 1221/1222 improves prediction of poor survival for breast cancer patients with hormone receptor-positive tumors di Thomas Frogne, Anne‐Vibeke Lænkholm, Maria Lyng, Katrine L. Henriksen, Anne E. Lykkesfeldt

    Pubblicazione 2009
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  3. 3
    Antiestrogen-resistant human breast cancer cells require activated Protein Kinase B/Akt for growth

    Antiestrogen-resistant human breast cancer cells require activated Protein Kinase B/Akt for growth di Thomas Frogne, J.S. Jepsen, S. S. Larsen, Cathrine K. Fog, B L Brockdorff, Anne E. Lykkesfeldt

    Pubblicazione 2005
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  4. 4
    Semi-quantitative scoring of potentially predictive markers for endocrine treatment of breast cancer: a comparison between whole sections and tissue microarrays

    Semi-quantitative scoring of potentially predictive markers for endocrine treatment of breast cancer: a comparison between whole sections and tissue microarrays di Katrine L. Henriksen, Birgitte Rasmussen, Anne E. Lykkesfeldt, Susann Møller, Bent Ejlertsen, Henning T. Mouridsen

    Pubblicazione 2006
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  5. 5
    High CDK6 Protects Cells from Fulvestrant-Mediated Apoptosis and is a Predictor of Resistance to Fulvestrant in Estrogen Receptor–Positive Metastatic Breast Cancer

    High CDK6 Protects Cells from Fulvestrant-Mediated Apoptosis and is a Predictor of Resistance to Fulvestrant in Estrogen Receptor–Positive Metastatic Breast Cancer di Carla L. Alves, Daniel Eliáš, Maria Lyng, Martin Bak, Tove Kirkegaard, Anne E. Lykkesfeldt, Henrik J. Ditzel

    Pubblicazione 2016
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  6. 6
    Lapatinib Restores Hormone Sensitivity with Differential Effects on Estrogen Receptor Signaling in Cell Models of Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer with Acquired Endocrine Resistance

    Lapatinib Restores Hormone Sensitivity with Differential Effects on Estrogen Receptor Signaling in Cell Models of Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer wi... di Alexandra Léary, Suzanne Drury, Simone Detre, Sunil Pancholi, Anne E. Lykkesfeldt, Lesley‐Ann Martin, Mitch Dowsett, Stephen Johnston

    Pubblicazione 2010
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  7. 7
    Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy

    Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy di Daniel Eliáš, Henriette Vever, Anne‐Vibeke Lænkholm, Morten F. Gjerstorff, Christina W. Yde, Anne E. Lykkesfeldt, Henrik J. Ditzel

    Pubblicazione 2014
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  8. 8
    Integrative analyses of gene expression and DNA methylation profiles in breast cancer cell line models of tamoxifen-resistance indicate a potential role of cells with stem-like properties

    Integrative analyses of gene expression and DNA methylation profiles in breast cancer cell line models of tamoxifen-resistance indicate a potential role of cells with stem-like pro... di Xue Lin, Jian Li, Guangliang Yin, Qian Zhao, Daniel Eliáš, Anne E. Lykkesfeldt, Jan Stenvang, Nils Brünner, Jun Wang, Huanming Yang, Lars Bolund, Henrik J. Ditzel

    Pubblicazione 2013
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  9. 9
    A kinase inhibitor screen identifies Mcl-1 and Aurora kinase A as novel treatment targets in antiestrogen-resistant breast cancer cells

    A kinase inhibitor screen identifies Mcl-1 and Aurora kinase A as novel treatment targets in antiestrogen-resistant breast cancer cells di Susan Thrane, ASTRID M. PEDERSEN, M B H Thomsen, T Kirkegaard, Birgitte Rasmussen, Anne Katrine Duun‐Henriksen, Anne‐Vibeke Lænkholm, Martin Bak, Anne E. Lykkesfeldt, Christina W. Yde

    Pubblicazione 2014
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  10. 10
    Classifications within Molecular Subtypes Enables Identification of BRCA1/BRCA2 Mutation Carriers by RNA Tumor Profiling

    Classifications within Molecular Subtypes Enables Identification of BRCA1/BRCA2 Mutation Carriers by RNA Tumor Profiling di Martin J. Larsen, Torben A. Kruse, Qihua Tan, Anne‐Vibeke Lænkholm, Martin Bak, Anne E. Lykkesfeldt, Kristina P. Sørensen, Thomas van Overeem Hansen, Bent Ejlertsen, Anne‐Marie Gerdes, Mads Thomassen

    Pubblicazione 2013
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  11. 11
    Activation of ErbB3, EGFR and Erk is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrant

    Activation of ErbB3, EGFR and Erk is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrant di Thomas Frogne, Rikke Vicki Benjaminsen, Katrine Sonne‐Hansen, Boe Sandahl Sørensen, Ebba Nexø, Anne‐Vibeke Lænkholm, Louise M. Rasmussen, David J. Riese, Patricia de Crémoux, Jan Stenvang, Anne E. Lykkesfeldt

    Pubblicazione 2008
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  12. 12
    FOXM1 is a transcriptional target of ERα and has a critical role in breast cancer endocrine sensitivity and resistance

    FOXM1 is a transcriptional target of ERα and has a critical role in breast cancer endocrine sensitivity and resistance di Julie Millour, Demetra Constantinidou, Alexandra Stavropoulou, Miranda Wilson, Stephen S. Myatt, Jimmy M-M. Kwok, Kavitta Sivanandan, R. Charles Coombes, René H. Medema, Johan Hartman, Anne E. Lykkesfeldt, Eric W.‐F. Lam

    Pubblicazione 2010
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:

Strumenti per la ricerca: